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ABSTRACT 
 
Castleman disease is a rare lymphoproliferative disorder. Only few cases 
reported worldwide since first describe in 1956. Only 2 percent of CD involve 
pararenal location. We report on a 16 years old lady with solitary Castleman 
disease of hyaline vascular type, involving right adrenal. Patient underwent right 
open adrenalectomy and no evidence of disease recurrence in 1 year follow up 
after surgery. In addition, we also discuss on the pathogenesis of the disease, 
clinical features and option of treatment. 
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ÖZET 
 
Castleman hastalığı nadir görülen bir lenfoproliferatif hastalıktır. İlk kez 1956'da 
tanımlandığından bu yana dünya çapında rapor edilen çok az vaka vardır. Bu 
yazıda, hyalin vasküler tipte soliter Castleman hastalığı olan ve sağ adrenal 
bulunan 16 yaşında bir kadın hasta sunuldu. Hastaya sağ açık adrenalektomi 
uygulandı ve cerrahi sonrası 1 yıllık takipte hastalık nüksü izlenmedi. Ek olarak, 
hastalığın patogenezi, klinik özellikleri ve tedavi seçeneği hakkında da 
tartışıyoruz. 
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INTRODUCTION 
 
Castleman disease or called as atypical lympho-proliferative disease or 
proliferative disease with uncertain malignant potential was first described by 
Castleman, Iverson and Menendez in 1956 (1) is a rare and heterogeneous 
disorder with few case series study have found a new knowledge of its disease 
natural history, etiology, outcome as well as the treatment option. 
  It has been suggested that anomalous proliferation of B lymphocytes in 
response to infectious or chronic stimuli in individuals with a genetic 
predisposition, autoimmunity or immunodeficiency disorder. We report on our 
first experience in surgical management of this uncommon condition and 
literature review on current treatment modalities on this disease. 
 
CASE REPORT 
 
A 16 year-old Javanese had suffered from worsening recurrent right 
hypochondric pain for 1 year duration, stabbing in nature, not associated with 
meal and usually it resolved spontaneously. Clinically she is morbidly obese with 
BMI of 40.2 with presence of striae on the abdomen and fullness of bilateral 
supraclavicular fat pad. Otherwise no other systemic symptoms and physical 
examination was unremarkable. Laboratory findings for renal, liver function and 
full blood count were within normal range. Sonography of abdomen shows no 
evidence of cholelithiasis or billiary obstruction. Noted right suprarenal mass 
with small right ovarian cyst, thus proceeded with CT abdomen and pelvis which 
reveal homogenous enhancing mass measuring 5.8 x 8.0 x 6.0 cm on right 
suprarenal adrenal mass, given the impression of likely an adenoma with mild 
central hypodence area to suggest necrosis. Mass was encapsulated, receiving 
blood supply direct from the abdominal aorta. . The left ovarian dermoid cyst 
measured 4.8 x 4.5 cm. CT adrenal with adrenal protocol shows relative 
percentage of washout of less than 40 percent, suggestive of malignant adrenal 
tumor. Further work out from endocrine team suggested that it was a non-
functional tumor. Patient was then underwent right adrenalectomy and 
recovered well post-operative. Histopathology examination of the tumor shows 
a lymphoid tissue composed of scattered lymphoid follicles with surrounding 
mature interfollicular lymphocytes with prominent vascular proliferation (Figure 
1). There were marked penetrating vessels and hyalinization seen traversed 
within the atretic germinal centers (Figure 2). Immunohistochemical study 
showed maintenance of non-neoplastic architecture of lymphoid follicles 
evidence by the presence of a network of CD21 positive dendritic follicular cells 
(figure 3). The mantle zones are thickened with multiple concentric layers of 
lymphocytes giving an onion skin appearance (figure 4). No mitosis or nuclear 
atypia noted giving a diagnosis of Castleman Disease (Giant lymph node 
hyperplasia), hyaline-vascular-type. Patient was followed up under surgery clinic 
for almost one year post right adrenalectomy and does not has any evidence of 
recurrence. 
 
 
Figure 1: Low power view showing lymphoid follicles with atretic germinal center 
and prominent vascular proliferation. (H&E, original magnification x10)  
 
 
 
Figure 2: Marked vascular and germinal center hyalinization. (H&E, original 
magnification x20) 
 
 
Figure 3: Presence of a network of CD21 positive dendritic follicular cells. 
(Immunohistochemical stain, original magnification x4)  
 
 
Figure 4: Thickened mantle zone with onion skin appearance layers of 
lymphocytes. (Immunohistochemical stain, original magnification x40)  
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DISCUSSION 
 
CD is a poorly understood disease that creates both diagnostic and therapeutic 
dilemmas for the treating physician . CD especially MCD can be a great mimicker 
of many other benign or malignant neoplasm. Due to presence of masses and 
lymphadenopathy, this will raise a suspicion of malignant tumor of lymphoma or 
metastatic tumor or even a benign condition of infectious and inflammatory 
disease (2). It is difficult to distinguished CD from other tumors if based on their 
clinical manifestations or radiological findings (3). Some reactive cause of 
lymphadenopathy may be indistinguishable from CD. A biopsy is required in 
particular to differentiate between lymphoma and disseminated CD. Proper 
histological evaluation is needed in order not to misdiagnose such cases.  
Generally it can be divided into two type, Unicentric Castleman disease (UCD) 
is localized disease and carries an excellent prognosis, whereas multicentric 
Castleman disease (MCD) is a systemic disease with poorer prognosis. It occur 
most commonly in the setting of HIV infection and is associated with human 
herpesvirus 8.(4). The therapeutic landscape for its management continues to 
evolve. 
Surgical resection is recommended for patients with the unicentric variant of 
CD and it is a curative measure for hyaline-vascular or hyaline-vascular/plasma 
cell type of UCD. Partial resection, radiotherapy, or observation alone may avoid 
the need for excessively aggressive therapy. Patients with multicentric disease 
usually do not benefit from surgical management and should be candidates for 
multimodality therapy, the nature of which has yet to be defined (5). Radiation 
therapy has been used with varied success in patients who are poor surgical 
candidates or in those with unresectable lesions. Long term follow-up is 
necessary with regard to malignant sequelae. The role of surgery in multicentric 
disease is limited and should not be considered a realistic treatment option. 
Systemic therapy in the form of steroids or single- or multiple-drug 
chemotherapies have all been used with varied success. However, there is no 
evidence for one approach being more consistently effective. This study also 
highlights a group of patients with multicentric disease and neuropathy for 
whom prognosis is poor and investigational treatment is justified.  
A better understanding of both the pathogenesis and the natural history of this 
disorder will lead to improvement over the current modalities available for 
treatment (5). 
 
CONCLUSION 
 
Castleman’s disease should be considered as a differential diagnosis in case well-
defined non-functional tumor in a patient without risk factors for malignancy or 
infection. Surgical excision is required for the diagnosis. Unicentric disease of 
hyaline vascular variant is associated with complete recovery after surgical 
resection. 
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